Feasibility and safety of the non-radial-specific 6 Fr FUBUKI XF guiding sheath for transradial neuroendovascular procedures

IF 1.8 4区医学 Q3 CLINICAL NEUROLOGY

Journal of Clinical Neuroscience Pub Date : 2025-09-04 DOI:10.1016/j.jocn.2025.111609

Daisuke Yamazaki , Akifumi Yokota , Daisuke Satoh , Takehiro Yako , Kazuo Kitazawa , Tetsuyoshi Horiuchi , Shigeaki Kobayashi

{"title":"Feasibility and safety of the non-radial-specific 6 Fr FUBUKI XF guiding sheath for transradial neuroendovascular procedures","authors":"Daisuke Yamazaki , Akifumi Yokota , Daisuke Satoh , Takehiro Yako , Kazuo Kitazawa , Tetsuyoshi Horiuchi , Shigeaki Kobayashi","doi":"10.1016/j.jocn.2025.111609","DOIUrl":null,"url":null,"abstract":"<div><div>The transradial approach (TRA) is gaining popularity in neuroendovascular therapy due to its safety and patient comfort, but its application in emergency settings with complex vascular anatomy remains technically demanding. This study assessed the feasibility and safety of using the 6 Fr FUBUKI XF long guiding sheath—a non-radial-specific device—for neuroendovascular procedures via TRA. Nineteen consecutive patients treated with the FUBUKI XF long guiding sheath between April 2024 and June 2025 were retrospectively reviewed and compared with a small cohort treated using the radial-specific Rist guiding sheath during the same period. The FUBUKI XF cohort had a mean age of 70.2 years, and 57.9 % were female. Most procedures (73.7 %) were for ruptured aneurysms. Anatomical challenges included type III aortic arch and aberrant right subclavian artery. Technical access success was achieved in 94.7 % of cases, with one case converted to transfemoral access. Median procedure time was 111.0 min (IQR, 72.0), median fluoroscopy time was 54.0 min (IQR, 35.3), and median DAP was 153.0 Gy·m<sup>2</sup> (IQR, 46.0). Intermediate catheters were employed in 94.7 % of procedures. One case of carotid dissection required stenting, but no major access-site complications occurred. The FUBUKI XF sheath’s atraumatic tip, flexible shaft, and high trackability enabled effective navigation and support. These findings suggest that the FUBUKI XF is a feasible and safe option for TRA-based neurointerventions, with performance comparable to radial-specific devices in complex anatomical scenarios.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"141 ","pages":"Article 111609"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S096758682500582X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The transradial approach (TRA) is gaining popularity in neuroendovascular therapy due to its safety and patient comfort, but its application in emergency settings with complex vascular anatomy remains technically demanding. This study assessed the feasibility and safety of using the 6 Fr FUBUKI XF long guiding sheath—a non-radial-specific device—for neuroendovascular procedures via TRA. Nineteen consecutive patients treated with the FUBUKI XF long guiding sheath between April 2024 and June 2025 were retrospectively reviewed and compared with a small cohort treated using the radial-specific Rist guiding sheath during the same period. The FUBUKI XF cohort had a mean age of 70.2 years, and 57.9 % were female. Most procedures (73.7 %) were for ruptured aneurysms. Anatomical challenges included type III aortic arch and aberrant right subclavian artery. Technical access success was achieved in 94.7 % of cases, with one case converted to transfemoral access. Median procedure time was 111.0 min (IQR, 72.0), median fluoroscopy time was 54.0 min (IQR, 35.3), and median DAP was 153.0 Gy·m² (IQR, 46.0). Intermediate catheters were employed in 94.7 % of procedures. One case of carotid dissection required stenting, but no major access-site complications occurred. The FUBUKI XF sheath’s atraumatic tip, flexible shaft, and high trackability enabled effective navigation and support. These findings suggest that the FUBUKI XF is a feasible and safe option for TRA-based neurointerventions, with performance comparable to radial-specific devices in complex anatomical scenarios.

查看原文本刊更多论文

非桡骨特异性6 Fr FUBUKI XF引导鞘用于经桡骨神经血管内手术的可行性和安全性

经桡骨入路（TRA）因其安全性和患者舒适度而在神经血管内治疗中越来越受欢迎，但其在血管解剖复杂的急诊环境中的应用仍然具有技术要求。本研究评估了使用6 Fr FUBUKI XF长引导鞘（一种非径向特异性装置）经TRA进行神经血管内手术的可行性和安全性。回顾性分析了2024年4月至2025年6月期间连续19例使用FUBUKI XF长引导鞘治疗的患者，并与同期使用放射特异性Rist引导鞘治疗的小队列进行了比较。FUBUKI XF队列的平均年龄为70.2岁，57.9%为女性。大多数手术（73.7%）用于动脉瘤破裂。解剖挑战包括III型主动脉弓和异常的右锁骨下动脉。技术通路成功率94.7%，其中经股动脉通路1例。中位手术时间为111.0 min (IQR, 72.0)，中位透视时间为54.0 min (IQR, 35.3)，中位DAP为153.0 Gy·m2 （IQR, 46.0）。94.7%的手术采用中间导管。1例颈动脉夹层需要支架植入，但没有发生主要的通路并发症。FUBUKI XF护套的自动尖端、灵活的轴和高跟踪性使其能够有效地导航和支撑。这些研究结果表明，FUBUKI XF是一种可行且安全的基于tra的神经干预选择，在复杂的解剖情况下，其性能可与放射特异性装置相媲美。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Neuroscience 医学-临床神经学

CiteScore

4.50

自引率

0.00%

发文量

402

审稿时长

40 days

期刊介绍： This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology. The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.